What is active surveillance for prostate cancer

Active Surveillance for Prostate Cancer: An Educational Overview

Active surveillance is a carefully monitored approach where men with early-stage prostate cancer are closely watched rather than immediately treated with surgery or radiation. Think of it as a "watch and wait" strategy with regular check-ins to catch any changes early.

How Active Surveillance Works

Instead of treating the cancer right away, your medical team monitors you through:

• Regular PSA blood tests (usually every 3-6 months initially)
• Digital rectal exams (DRE) to feel the prostate
• Repeat prostate biopsies (typically every 1-2 years) to check if the cancer is changing
• Imaging studies if there are signs of progression

The goal is to avoid or delay the side effects of surgery and radiation while keeping close watch for any signs that the cancer is becoming more aggressive.

Why Doctors Consider Active Surveillance

According to the NCCN (National Comprehensive Cancer Network) Guidelines for Prostate Cancer, active surveillance may be appropriate for men with:

• Low-risk disease (early stage, slow-growing tumors)
• Good overall health and life expectancy of 10+ years
• Ability to commit to regular monitoring appointments
• Preference to avoid immediate treatment side effects

The clinical reasoning is that many early prostate cancers grow very slowly—some men may never need treatment during their lifetime. However, some cancers do progress, which is why monitoring is essential.

Key Differences from "Watchful Waiting"

These terms are sometimes confused:

• Active Surveillance = Regular monitoring with intent to treat if progression occurs
• Watchful Waiting = Monitoring with focus on symptom management rather than curative treatment (often used for older men or those with limited life expectancy)

Questions to Ask Your Oncology Team

If active surveillance is being discussed for your situation:

1. "Based on my specific biopsy results and PSA level, do I meet criteria for active surveillance?"
2. "How often would I need PSA tests and biopsies, and what changes would trigger treatment?"
3. "What are the potential risks of delaying treatment, and how would you monitor for those?"
4. "What treatment options would be available if my cancer shows signs of progression?"
5. "How do my age, overall health, and personal preferences factor into this decision?"

Important Context

According to the American Cancer Society, active surveillance has become increasingly common for low-risk prostate cancer because research shows it can safely delay or avoid treatment in many men while maintaining excellent outcomes. However, it requires commitment to follow-up care and regular appointments.

Your oncologist will determine whether active surveillance is appropriate for YOUR specific situation based on your complete clinical picture, including your biopsy findings, PSA level, age, health status, and personal preferences.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.